Neurological complications of
Anderson-Fabry disease. Curr Pharm Des.
Miners, "
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females," Journal of Medical Genetics, vol.
Anderson-Fabry disease (AFD) is an X-linked disease of lysosomal metabolism resulting in attenuated activity or absence of the enzyme alpha-galactosidase A (a-Gal A).
Renal involvement in
Anderson-Fabry disease. J Nephrol.
Anderson-Fabry Disease.
Anderson-Fabry disease is a rare X-linked recessive lysosomal storage disorder, caused by mutations of the GLA gene that encodes [alpha]-galactosidase A which breaks down neutral glycosphingolipids [85].
The neurological complications of
Anderson-Fabry disease (alpha-galactosidase A deficiency)-investigation of symptomatic and presymptomatic patients.
Anderson-Fabry disease, a commonly missed diagnosis.
(2008) Effects of enzyme replacement therapy on the cardiomyopathy of
Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Her GP treated her symptoms with antibiotics and doctors who treated her for 10 days at Belfast's Mater Hospital suspected Miss Best was suffering from vertigo or
Anderson-Fabry disease, which leaves victims with painful pustules over all their body.